Boston Scientific (BSX) Land & Improvements (2025 - 2026)
Boston Scientific's (BSX) quarterly Land & Improvements came in at $183.0 million in Q2 2026, down 2.66% quarter-over-quarter from $188.0 million in Q1 2026.
Powered by 
Analysis
Boston Scientific (BSX) Land & Improvements (2025 - 2026) Analysis & Trends
Boston Scientific has disclosed Land & Improvements across 2 years of filings, most recently posting $183.0 million for Q2 2026.
- In Q2 2026, Land & Improvements changed N/A year-over-year to $183.0 million; the TTM figure through Jun 2026 stood at $183.0 million (changed N/A YoY), while the FY2025 annual figure was $173.0 million, changed N/A from the prior year.
- Land & Improvements came in at $183.0 million for Q2 2026 at Boston Scientific, down from $188.0 million in the prior quarter.
- In the past five years, Land & Improvements ranged from a high of $188.0 million in Q1 2026 to a low of $173.0 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Land & Improvements (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | - |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | - |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | 1.81 Bn |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | 183.00 Mn |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | - |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | - |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | 112.50 Mn |
| 10 | Zimmer Biomet Holdings | 18.20 Bn | 17.79 Bn | 1.54 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 183.00 Mn |
| Mar 31, 2026 | 188.00 Mn |
| Dec 31, 2025 | 173.00 Mn |